Imunoglobulina humana por via subcutânea para imunodeficiências primárias
Subcutaneous immunoglobulin therapy for primary immunodeficiencies
Ekaterini Simões Goudouris; Almerinda Maria Rego Silva; Aluce Loureiro Ouricuri; Anete Sevciovic Grumach; Antonio Condino Neto; Beatriz Tavares Costa Carvalho; Cristina Maria Kokron; Dewton de Moraes Vasconcelos; Gesmar Rodrigues Silva Segundo; Mayra de Barros Dorna; Myrthes Anna Maragna Toledo Barros; Wilma Carvalho Neves Forte
Referências
1. Shapiro RS. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics. Pediatr Allergy Immunol. 2013;24(1):49-53.
2. Chapel H, Gardulf A. Subcutaneous immunoglobulin replacement therapy: the European experience. Curr Opin Allergy Clin Immunol. 2013;13(6):623-9.
3. Saeedian M, Randhawa I. Immunoglobulin replacement therapy: a twenty-year review and current update. Int Arch Allergy Immunol. 2014;164(2):151-66.
4. Seitz R, Behr-Gross M, Bucheit K, Schramm W, Berger K, Hilger A, et al. European consensus proposal for immunoglobulin therapies. Eur J Immunol. 2014;44:2207-14.
5. Jolles S, Orange JS, Gardulf A, Stein MR, Shapiro R, Borte M, et al. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015;179(2):146‑60.
Facebook
LinkedIn
Mendeley
StumbleUpon
Reddit
Email